Managed Care Update: Improving Outcomes for Narcolepsy
Jointly provided by
Impact Education, LLC    
This activity is supported by an independent educational grant from Jazz Pharmaceuticals, Inc.

Managed Care Update: Improving Outcomes for Narcolepsy

Live Webcast Date

December 11, 2018 | 1:30pm to 3:00pm EST

Coming Soon: An On-demand CE Archive of this Webcast

  • Facilitate timely claims/prior authorization approval and treatment
  • Standardize use of validated scales and patient questionnaires for identifying narcolepsy
  • Assess current pharmacologic treatments for narcolepsy
  • Identify value-driven assessment approaches for member drug benefit design
Jeffrey D. Dunn, PharmD, MBA
Vice President
Clinical Strategy and Programs and Industry Relations
MagellanRx Management
John Fox, MD, MHA
Vice President, Associate Chief Medical Officer
Medical Affairs
Priority Health
Phyllis C. Zee, MD, PhD
Benjamin and Virginia Professor in Neurology
Chief, Division of Sleep Medicine
Director, Center for Circadian and Sleep Medicine
Northwestern University Feinberg School of Medicine
  • Managed care pharmacy directors, clinical pharmacists, quality directors, medical directors
  • Pharmacy directors, specialty pharmacists, quality directors, care managers, registered nurses, and other managed care and payer organization professionals

Resulting in part from a lack of awareness regarding disease burden, under-recognition of symptoms, and misdiagnoses related to potential psychiatric comorbidities, narcolepsy represents a therapeutic area with several important practice gaps and unmet clinical needs in managed care. This educational activity seeks to address these gaps and needs in a logical, stepwise process by focusing on raising disease awareness among managed care professionals to establish the impetus for intervention and change in administrative and/or practice behaviors. Efficient and accurate diagnosis on the part of network providers will be promoted, followed by a payer-centric assessment of the value of available pharmacologic treatments and other therapeutic interventions. In addition to benefit design considerations such as timely and efficient prior authorization approvals surrounding these treatment modalities, the activity will detail the parameters of a successful care coordination model for narcolepsy, in which managed care stakeholders are empowered to facilitate effective, multidisciplinary care.


After completing the activity, participants should be better able to:
  • Outline the current diagnostic criteria for narcolepsy and identify associated procedures to facilitate timely claims/prior authorization approval and treatment
  • Describe the available validated scales and patient questionnaires for identifying narcolepsy symptoms and evaluate their respective benefits and disadvantages for standardized use among network providers
  • Evaluate current pharmacologic treatments for narcolepsy based on available efficacy, safety, and cost data
  • Incorporate value-driven assessment approaches for member drug benefit design and appropriate formulary positioning of narcolepsy therapies
  • Implement plan-wide initiatives to better coordinate care for narcolepsy among primary care physicians, sleep specialists, and ancillary providers
Opening Comments/Overview
Jeffrey D. Dunn, PharmD, MBA
Clinical, Economic, and Humanistic Impact of Narcolepsy in a Managed Care Setting
Phyllis C. Zee, MD, PhD
Medical Management and Stream-Lined Prior Authorization Approval to Enhance Outcomes for Narcolepsy
John Fox, MD, MHA
Narcolepsy Care Coordination for Optimal Outcomes
Jeffrey D. Dunn, PharmD, MBA
Faculty Idea Exchange
Audience Question and Answer Session

Key Takeaways and Closing Comments
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008162-9999-18-442-L01-P
Type of Activity: Application

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.

Fee Information
There is no fee for this educational activity.

Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.

If you have any questions, please call (215) 619-8812 or email